INVIVYD, INC.

Lobbying for INVIVYD, INC. · education and awareness related to COVID-19 therapeutics

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $60,000.00 expenses · posted Jun 24, 2026

Lobbying activity 2

Manufacturing

Onshoring, Domestic manufacturing

Health Issues

Monoclonal Antibodies, Infectious diseases

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.